Purple Cells - New Leukemia Treatment

This piece reports a gene therapy success against chronic lymphocytic leukemia for three patients at the University of Pennsylvania Cancer Center.  The technique involved a recombinant viral vector engineered to express two antigens receptors found in CD19 positive malignancies (which is a subset of all CLL cancers).  The virus transformed the patients own expanded T-cells against this cancer.  Investigators in this trial also believe that their approach would work in non-Hodgkin lymphoma and acute lymphocytic leukemia. MORE

Image Credit:  University of Pennsylvania and Genetic Engineering and Biotechnology News